Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?

Literature DB >> 29897557

Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?

Karen K Winer¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
Parathyroid Hormone

Year: 2018 PMID： 29897557 PMCID： PMC6276667 DOI： 10.1210/jc.2017-02593

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

× No keyword cloud information.

24 in total

1. Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.

Authors: T Sikjaer; L Rolighed; A Hess; A Fuglsang-Frederiksen; L Mosekilde; L Rejnmark
Journal: Osteoporos Int Date: 2014-04-01 Impact factor: 4.507

2. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

Authors: K K Winer; J A Yanovski; G B Cutler
Journal: JAMA Date: 1996-08-28 Impact factor: 56.272

Review 3. Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.

Authors: Matthias Büttner; Thomas J Musholt; Susanne Singer
Journal: Endocrine Date: 2017-08-18 Impact factor: 3.633

Review 4. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.

Authors: Gemma Marcucci; Giuseppe Della Pepa; Maria Luisa Brandi
Journal: Expert Opin Drug Saf Date: 2017-04-03 Impact factor: 4.250

5. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.

Authors: Andrea Palermo; Assunta Santonati; Gaia Tabacco; Daniela Bosco; Antonio Spada; Claudio Pedone; Bruno Raggiunti; Tina Doris; Daria Maggi; Franco Grimaldi; Silvia Manfrini; Fabio Vescini
Journal: J Clin Endocrinol Metab Date: 2018-01-01 Impact factor: 5.958

6. Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Authors: Karen K Winer; Bo Zhang; Joseph A Shrader; Donna Peterson; Michaele Smith; Paul S Albert; Gordon B Cutler
Journal: J Clin Endocrinol Metab Date: 2011-11-16 Impact factor: 5.958

7. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.

Authors: Wiebke Arlt; Christian Fremerey; Frank Callies; Martin Reincke; Peter Schneider; Wolfgang Timmermann; Bruno Allolio
Journal: Eur J Endocrinol Date: 2002-02 Impact factor: 6.664

8. The effect of PTH(1-84) on quality of life in hypoparathyroidism.

Authors: Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Dinaz Irani; Amanda Tulley; James Sliney; John P Bilezikian
Journal: J Clin Endocrinol Metab Date: 2013-04-17 Impact factor: 5.958

9. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.

Authors: Mishaela R Rubin; Natalie E Cusano; Wen-Wei Fan; Yasmine Delgado; Chengchen Zhang; Aline G Costa; Serge Cremers; Elzbieta Dworakowski; John P Bilezikian
Journal: J Clin Endocrinol Metab Date: 2016-05-04 Impact factor: 5.958

10. Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.

Authors: Marianne C Astor; Kristian Løvås; Aleksandra Debowska; Erik F Eriksen; Johan A Evang; Christian Fossum; Kristian J Fougner; Synnøve E Holte; Kari Lima; Ragnar B Moe; Anne Grethe Myhre; E Helen Kemp; Bjørn G Nedrebø; Johan Svartberg; Eystein S Husebye
Journal: J Clin Endocrinol Metab Date: 2016-05-17 Impact factor: 5.958

4 in total